Biotech Catalysts
Trial readouts and drug decisions coming up for listed companies, with every date change kept.
Every industry trial on ClinicalTrials.gov whose sponsor is a listed company: status, phase, enrollment and the primary completion date analysts watch, versioned at each registry update, so slipping readouts are visible. Plus FDA approvals and complete response letters (openFDA), FDA advisory committee meetings (Federal Register), EMA opinions and authorisations, and Health Canada notices of compliance.
Questions it answers
- Which readouts are due next quarter, and have their dates slipped?
- What did the FDA or EMA decide, and when?
Use cases
- Catalyst calendars for biotech funds
- Date-slip signals
- Regulatory decision tracking across the US, EU and Canada
- Coverage
- 64,193 values; 767 companies
- History
- Back to 1994
- Update frequency
- Every 15 minutes to weekly, by source
- Key fields
- Trial phase, status, primary completion date (actual or estimated), enrollment; approvals, CRLs, AdCom dates, EMA status
- Point in time
- Registry and regulator changes versioned at their posted dates
- Sources
- ClinicalTrials.gov API · openFDA (drugs@FDA, transparency data) · Federal Register (FDA advisory committees) · European Medicines Agency data file · Health Canada NOC API
- Licence
- US: public domain. EMA and Health Canada: delivered with the source credited
- Delivery
- Data API · MCP · Python SDK · Excel · S3/Snowflake files · App
Data as of 2 November 2026
Each value carries the time it became public and the time Factget first saw it. Corrections and restatements are new versions; earlier versions stay queryable, so a backtest only sees what was known on each date. The source file behind every value is stored unaltered.
Build a datasetfrom your sources.
Tell us the sources and the fields you need. We’ll show you what factget can build, and keep current.